Resources

AVAC’s Resource Database contains educational and advocacy materials covering a wide range of issues on biomedical prevention of HIV, STIs, COVID-19 and emerging health threats—from research to rollout.

To search for clinical trials and detailed information on products in development, visit our Prevention Research & Development Database

Results

showing 1-10 of 767

ICASA 2023 Prevention Roadmap

View the ICASA roadmap for details on sessions that help to:

November 2023


Call to Action for Voluntary Medical Male Circumcision

In the pursuit of a future without HIV and AIDS, voluntary medical male circumcision (VMMC) remains an integral component of the arsenal in HIV prevention, offering a cost-effective and scientifically proven intervention that holds immense potential in curbing the acquisition of HIV.

November 2023


PxWire Volume 13, Issue No. 4

PxWire is AVAC’s quarterly update covering the latest in the field of biomedical HIV prevention research and development, implementation and advocacy. Each issue includes updates, emerging issues and upcoming events. Also available as a PDF. From...

Prevention Option:

November 2023


African Civil Society Mobilization for PEPFAR Reauthorization

Tuesday, November 28 at 7:00 AM ET Moderator: Richard Muko, Regional Implementation Advocacy Manager, AVAC Panelists: Joan Chamungu, Tanzanian Network of Women Living with HIV, Lawrence Khonyongwa, Malawi Network of People of Living with...

Prevention Option:

November 2023


Pandemic Accord Briefing for Civil Society & Community Partners

The Pandemic Accord negotiations are ongoing, and should come to fruition next year. What do they mean for your work, your country, and the future of global health? On Tuesday, November 21, 8:00 to 9:30 AM EST / 2:00 to 3:30 PM CEST, advocates came...

Prevention Option:

November 2023


Spotlight on New PrEP Tools and Data: From R&D to access

Tuesday, November 28 Between the recent accelerated growth in global PrEP initiations, and the introduction of new PrEP products like cabotegravir and the dapivirine vaginal ring, the field of PrEP data has never been more exciting or more...

Prevention Option:

November 2023


Years Ahead in HIV Prevention Research: Time to Market

This timeline shows the potential time points when the next-generation of HIV prevention options might find their way into new programs.

November 2023


From the Lab to the Jab

From the Lab to Jab are a series of briefs to learn the latest in vaccine R&D for HIV, COVID-19, TB and other global public health threats.

November 2023


Local Vaccine Production: Harnessing Its Potential for Equity

This issue brief on local vaccine production covers the current state of local production, what is needed to facilitate it, and ideas for advocacy to harness its potential.

Prevention Option:

November 2023


mRNA Technology: What It Might Mean for Future Vaccines

This issue brief on mRNA technology covers what it is, how it works, current knowledge gaps and ideas for advocacy to harness its potential.

Prevention Option:

November 2023


showing 1-10 of 767